In fact, one clinical study of obese patients published in Nature Metabolism in 2023 found that those treated with liraglutide saw significant improvement in a range of associative learning tasks versus the placebo group
Go low and slow Incretin-based medicines are typically started at a minimum dose, and the dose increases each month or so
Store vials in amber glass when possible, or wrap clear vials in aluminum foil
The clinical results of both GLP-1 drugs, especially tirzepatide, are impressive
Researchers are studying how they impact a range of different health issues including (but not limited to): Sleep apnea Metabolic disorders Neurodegenerative disorders Substance use disorders Liver disease Arthritis Inflammatory bowel disease Completing research studies and gaining FDA approval for new use cases takes time, but it looks likely that GLP-1s could be prescribed as treatment for a growing list of health issues in the coming years
Explore How RejuvaCare LeanPatch Works Ingredient Breakdown RejuvaCare LeanPatch uses a botanical blend that the company describes as designed to naturally encourage GLP-1 activity and support fat metabolism through transdermal absorption